ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 97 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,228,000 | -50.3% | 48,650 | -25.7% | 0.10% | -57.3% |
| Q3 2020 | $2,470,000 | -16.7% | 65,510 | -5.4% | 0.25% | -15.2% |
| Q2 2020 | $2,964,000 | +88.9% | 69,240 | -14.2% | 0.29% | +64.8% |
| Q1 2020 | $1,569,000 | -25.1% | 80,690 | 0.0% | 0.18% | -12.0% |
| Q4 2019 | $2,096,000 | -13.4% | 80,690 | -9.1% | 0.20% | -18.0% |
| Q3 2019 | $2,419,000 | +1.5% | 88,760 | 0.0% | 0.24% | +37.1% |
| Q2 2019 | $2,383,000 | – | 88,760 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |